deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT04295759

INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas

A Phase I Study of the Adam-10 Inhibitor, INCB7839 in Children With Recurrent/Progressive High-Grade Gliomas to Target Microenvironmental Neuroligin-3

Sponsor: American Lebanese Syrian Associated Charities

Interventions INCB7839
Updated 23 times since 2020 Last updated: Dec 12, 2025 Started: Jul 27, 2020 Primary completion: Dec 31, 2023 Completion: Dec 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04295759, this PHASE1 trial focuses on Anaplastic Astrocytoma and Anaplastic Oligodendroglioma and remains completed. Sponsored by American Lebanese Syrian Associated Charities, it has been updated 23 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshot~Jun 2020 – ~Dec 2020 · 6 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshot~Feb 2022 – ~May 2022 · 3 months · monthly snapshot~May 2022 – ~Sep 2022 · 4 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Feb 2024 · 8 months · monthly snapshot~Feb 2024 – ~Apr 2024 · 2 months · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Dec 2024 · 2 months · monthly snapshot~Dec 2024 – ~Mar 2025 · 3 months · monthly snapshot~Mar 2025 – ~Aug 2025 · 5 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 6 months · monthly snapshot

Change History

23 versions recorded
  1. Feb 2026 — Present [monthly]

    Completed PHASE1

  2. Sep 2025 — Feb 2026 [monthly]

    Completed PHASE1

  3. Aug 2025 — Sep 2025 [monthly]

    Completed PHASE1

  4. Mar 2025 — Aug 2025 [monthly]

    Completed PHASE1

    Status: Active Not RecruitingCompleted

  5. Dec 2024 — Mar 2025 [monthly]

    Active Not Recruiting PHASE1

Show 18 earlier versions
  1. Oct 2024 — Dec 2024 [monthly]

    Active Not Recruiting PHASE1

  2. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

  4. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

  5. Apr 2024 — May 2024 [monthly]

    Active Not Recruiting PHASE1

  6. Feb 2024 — Apr 2024 [monthly]

    Active Not Recruiting PHASE1

  7. Jun 2023 — Feb 2024 [monthly]

    Active Not Recruiting PHASE1

    Status: RecruitingActive Not Recruiting

  8. Apr 2023 — Jun 2023 [monthly]

    Recruiting PHASE1

  9. Feb 2023 — Apr 2023 [monthly]

    Recruiting PHASE1

  10. Dec 2022 — Feb 2023 [monthly]

    Recruiting PHASE1

    Status: Active Not RecruitingRecruiting

  11. Sep 2022 — Dec 2022 [monthly]

    Active Not Recruiting PHASE1

  12. May 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE1

    Status: RecruitingActive Not Recruiting

  13. Feb 2022 — May 2022 [monthly]

    Recruiting PHASE1

  14. Oct 2021 — Feb 2022 [monthly]

    Recruiting PHASE1

    Status: Active Not RecruitingRecruiting

  15. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE1

  16. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

    Status: RecruitingActive Not Recruiting

  17. Jun 2020 — Dec 2020 [monthly]

    Recruiting PHASE1

    Status: Not Yet RecruitingRecruiting

  18. Apr 2020 — Jun 2020 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • American Lebanese Syrian Associated Charities
  • National Cancer Institute (NCI)
  • Pediatric Brain Tumor Consortium
Data source: Pediatric Brain Tumor Consortium

For direct contact, visit the study record on ClinicalTrials.gov .